1. Home
  2. LEGN vs EAT Comparison

LEGN vs EAT Comparison

Compare LEGN & EAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • EAT
  • Stock Information
  • Founded
  • LEGN 2014
  • EAT 1975
  • Country
  • LEGN United States
  • EAT United States
  • Employees
  • LEGN N/A
  • EAT N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • EAT Restaurants
  • Sector
  • LEGN Health Care
  • EAT Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • EAT Nasdaq
  • Market Cap
  • LEGN 5.4B
  • EAT 7.3B
  • IPO Year
  • LEGN 2020
  • EAT N/A
  • Fundamental
  • Price
  • LEGN $38.96
  • EAT $164.51
  • Analyst Decision
  • LEGN Strong Buy
  • EAT Hold
  • Analyst Count
  • LEGN 12
  • EAT 16
  • Target Price
  • LEGN $73.91
  • EAT $149.00
  • AVG Volume (30 Days)
  • LEGN 1.6M
  • EAT 1.4M
  • Earning Date
  • LEGN 08-08-2025
  • EAT 08-13-2025
  • Dividend Yield
  • LEGN N/A
  • EAT N/A
  • EPS Growth
  • LEGN N/A
  • EAT 113.08
  • EPS
  • LEGN N/A
  • EAT 7.16
  • Revenue
  • LEGN $728,303,000.00
  • EAT $5,130,500,000.00
  • Revenue This Year
  • LEGN $65.49
  • EAT $22.10
  • Revenue Next Year
  • LEGN $53.76
  • EAT $4.93
  • P/E Ratio
  • LEGN N/A
  • EAT $23.04
  • Revenue Growth
  • LEGN 112.46
  • EAT 19.80
  • 52 Week Low
  • LEGN $27.34
  • EAT $56.27
  • 52 Week High
  • LEGN $60.87
  • EAT $192.22
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 66.26
  • EAT 39.76
  • Support Level
  • LEGN $34.64
  • EAT $170.30
  • Resistance Level
  • LEGN $39.88
  • EAT $184.56
  • Average True Range (ATR)
  • LEGN 1.46
  • EAT 6.55
  • MACD
  • LEGN 0.37
  • EAT -2.73
  • Stochastic Oscillator
  • LEGN 87.67
  • EAT 8.54

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About EAT Brinker International Inc.

Brinker International Inc operates casual dining restaurants under the brand's Chili Grill and Bar (Chili's) and Maggiano's Little Italy (Maggiano's). Chili's falls in the Bar and Grill category of casual dining. Its menu features Fresh Mex and Fresh Tex favorites including signature items such as slow-smoked baby back ribs, craft burgers, fajitas, and bottomless chips and salsa paired with tableside guacamole. Maggiano's is an Italian restaurant brand with a full lunch and dinner menu offering chef-prepared, such as appetizers, chicken, seafood, veal and prime steaks, and desserts. The company generates maximum revenue from Chili's segment.

Share on Social Networks: